A searchable  list of the publications within the Unit is available here. Key publications include:

• Griffin SJ, Leaver JK and Irving GJ. Impact of metformin on cardiov ascular disease: a meta-analysis of randomised trials among people w ith type 2 diabetes. Diabetologia. 2017; 10.1007/s00125-017-4337-9.
• Irving G, Neves AL, Dambha-Miller H, et al. International variations in primary care physician consultation time: a systematic review of 67 countries. BMJ open. 2017; 7: e017902
• Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ. External validation of risk prediction models for incident colorectal cancer using UK Biobank. British Journal of Cancer In press
• Usher-Smith JA, Emery J, Hamilton W, Griffin SJ, Walter FM. (2015) Risk Prediction Tools for Cancer in Primary Care. British Journal of Cancer. 113(12):1645-50. doi: 10.1038/bjc.2015.409
• Usher-Smith JA, Sharp SJ, Griffin SJ. The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ 2016;353:i3139.
• Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ. Lifestyle advice combined with personalized estimates of genetic or phenotypic risk of type 2 diabetes, and objectively measured physical activity: A randomized controlled trial. PLoS Med 2016;13:e1002185.
• Simmons R, Echouffo-Tcheugui J, Sharp S, Sargeant L, Williams K, Prevost T. Kinmonth A, Wareham N, Griffin SJ. Screening for type 2 diabetes on population mortality over ten years: the ADDITION-Cambridge cluster-randomised controlled trial. Lancet 2012; 380: 1741-8.
• Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GEHM, Sandbæk A, Sharp SJ, Simmons RK, van den Donk M, Wareham NJ, Lauritzen T. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011;378:156-167.
• Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ 2010;340:c1693.
• Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Couper DJ, Crawford G, Doney ASF, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PRV, Jørgensen T, Kao WHL, Klopp N, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Perry JRB, Petersen A-K, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, The MAGIC investigators, The GIANT consortium, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Mohlke KL, Morris AD, Palmer CAN, Pramstaller PP, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS, Pedersen O, Wichmann H-E, Barroso I, Florez JC, Frayling TM, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579–589.
• Paddison CAM, Eborall HC, Sutton S, French DP, Vasconcelos J, Prevost AT, Kinmonth AL, Griffin SJ. Are people with negative screening tests falsely reassured? A parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2009;339:b4535.
• Simmons RK, Sharp S, Boekholdt SM, Sargeant LA, Khaw KT, Wareham NJ, Griffin SJ. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated haemoglobin improve the prediction of coronary heart disease events? Archives of Internal Medicine 2008;168:1209-1216.
• Kinmonth A-L, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T, Williams KM, Ekelund U, Spiegelhalter D, Griffin SJ. Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet 2008;371:41-48.
• van Sluijs EMF, McMinn A, Griffin SJ. Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. BMJ 2007;335:703-707.
• Yerrakalva D, Cooper AJ, Khaw KT, Wareham NJ, Brage S, Griffin SJ, Wijndaele KL. The Descriptive Epidemiology of the Diurnal Profile of Bouts and Breaks in Sedentary Time in English Older Adults.  Int J Epidemiol 2017; doi: 10.1093/ije/dyx123.
• Dambha-Miller H, Cooper AJM, Kinmonth AL, Griffin SJ. Effect on cardiovascular disease risk factors of interventions to alter consultations between practitioners and patients with type 2 diabetes: A systematic review and meta-analysis of trials in primary care. Health Expectations 2017; 20:1218–1227.
• Ward RJ, Heald AH, Ogunmekan S, Fryer AA, Duff CJ. Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus? British Journal of General Practice. Feb 2018; pp 94-95
• Usher-Smith JA, Silarova B, Sharp SJ, Mills K, Griffin S. The impact of cancer risk based interventions to people at population level risk: a systematic review and meta-analysis. BMJ Open 2018;8 :e017717. doi:10.1136/bmjopen-2017-017717.
• Mills K, Harte E, Martin A, Maclure C, Griffin S, Mant J, Meads C, Saunders C, Walter FM, Usher-Smith JA. Views of commissioners, managers and healthcare professionals on the NHS Health Check programme: a systematic review. BMJ Open, 2017; 7 :e018606. doi:10.1136/bmjopen-2017-018606.
• Griffin SJ, Kinmonth AL, Veltman MW, Gillard S, Grant J and Stewart M. Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials. Ann Fam Med. 2004; 2: 595-608.